These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22519511)

  • 1. Boron containing compounds as protease inhibitors.
    Smoum R; Rubinstein A; Dembitsky VM; Srebnik M
    Chem Rev; 2012 Jul; 112(7):4156-220. PubMed ID: 22519511
    [No Abstract]   [Full Text] [Related]  

  • 2. Docking of noncompetitive inhibitors into dengue virus type 2 protease: understanding the interactions with allosteric binding sites.
    Othman R; Kiat TS; Khalid N; Yusof R; Newhouse EI; Newhouse JS; Alam M; Rahman NA
    J Chem Inf Model; 2008 Aug; 48(8):1582-91. PubMed ID: 18656912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of nonpeptide, peptidomimetic peptidase inhibitors that target alternate enzyme active site conformations.
    Rich DH; Bursavich MG; Estiarte MA
    Biopolymers; 2002; 66(2):115-25. PubMed ID: 12325161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of several small-size HTLV-I protease inhibitors with different hydrophilicity profiles.
    Nguyen JT; Kato K; Hidaka K; Kumada HO; Kimura T; Kiso Y
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2425-9. PubMed ID: 21392990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity-based fingerprinting of proteases.
    Srinivasan R; Huang X; Ng SL; Yao SQ
    Chembiochem; 2006 Jan; 7(1):32-6. PubMed ID: 16317790
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of macromolecular protease inhibitors.
    Farady CJ; Craik CS
    Chembiochem; 2010 Nov; 11(17):2341-6. PubMed ID: 21053238
    [No Abstract]   [Full Text] [Related]  

  • 7. A continuous-flow mass biosensor for the real-time dynamic analysis of protease inhibition.
    Huang Y; Zhang Q; Liu G; Zhao R
    Chem Commun (Camb); 2015 Apr; 51(30):6601-4. PubMed ID: 25776796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yin and Yang in the proteolytic landscape.
    Lalmanach G
    Biochimie; 2010 Nov; 92(11):v-vii. PubMed ID: 21050960
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and biological characterization of argyrin F.
    Bülow L; Nickeleit I; Girbig AK; Brodmann T; Rentsch A; Eggert U; Sasse F; Steinmetz H; Frank R; Carlomagno T; Malek NP; Kalesse M
    ChemMedChem; 2010 Jun; 5(6):832-6. PubMed ID: 20358576
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteases universally recognize beta strands in their active sites.
    Tyndall JD; Nall T; Fairlie DP
    Chem Rev; 2005 Mar; 105(3):973-99. PubMed ID: 15755082
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting proteases: successes, failures and future prospects.
    Turk B
    Nat Rev Drug Discov; 2006 Sep; 5(9):785-99. PubMed ID: 16955069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidase inhibitors in the MEROPS database.
    Rawlings ND
    Biochimie; 2010 Nov; 92(11):1463-83. PubMed ID: 20430064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage display as a powerful tool to engineer protease inhibitors.
    Zani ML; Moreau T
    Biochimie; 2010 Nov; 92(11):1689-704. PubMed ID: 20470858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cucurbit[7]uril on enzymatic activity.
    Hennig A; Ghale G; Nau WM
    Chem Commun (Camb); 2007 Apr; (16):1614-6. PubMed ID: 17530077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture.
    Steuer C; Gege C; Fischl W; Heinonen KH; Bartenschlager R; Klein CD
    Bioorg Med Chem; 2011 Jul; 19(13):4067-74. PubMed ID: 21641807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arresting malaria parasite egress from infected red blood cells.
    Lee MC; Fidock DA
    Nat Chem Biol; 2008 Mar; 4(3):161-2. PubMed ID: 18277974
    [No Abstract]   [Full Text] [Related]  

  • 17. Small peptide inhibitors of acetyl-peptide hydrolase having an uncommon mechanism of inhibition and a stable bent conformation.
    Sandomenico A; Russo A; Palmieri G; Bergamo P; Gogliettino M; Falcigno L; Ruvo M
    J Med Chem; 2012 Mar; 55(5):2102-11. PubMed ID: 22309188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The medicinal chemistry of protease inhibitors.
    Diederich WE; Wegscheid-Gerlach C
    Curr Top Med Chem; 2010; 10(3):231. PubMed ID: 20374196
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of protease and protease inhibitors in cancer pathogenesis and treatment.
    Eatemadi A; Aiyelabegan HT; Negahdari B; Mazlomi MA; Daraee H; Daraee N; Eatemadi R; Sadroddiny E
    Biomed Pharmacother; 2017 Feb; 86():221-231. PubMed ID: 28006747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
    Nitsche C; Steuer C; Klein CD
    Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.